NO137965C - Analogifremgangsmaate for fremstilling av nye cykliske terapeutisk aktive urinstoffderivater og salter av disse med farmasoeytisk akseptable syrer - Google Patents

Analogifremgangsmaate for fremstilling av nye cykliske terapeutisk aktive urinstoffderivater og salter av disse med farmasoeytisk akseptable syrer

Info

Publication number
NO137965C
NO137965C NO3522/72A NO352272A NO137965C NO 137965 C NO137965 C NO 137965C NO 3522/72 A NO3522/72 A NO 3522/72A NO 352272 A NO352272 A NO 352272A NO 137965 C NO137965 C NO 137965C
Authority
NO
Norway
Prior art keywords
salts
preparation
pharmaceutical acceptable
acceptable acids
therapeutic active
Prior art date
Application number
NO3522/72A
Other languages
English (en)
Norwegian (no)
Other versions
NO137965B (no
Inventor
Rolf Rebling
Klaus Pressler
Juergen Potel
Original Assignee
Asta Werke Ag Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Werke Ag Chem Fab filed Critical Asta Werke Ag Chem Fab
Publication of NO137965B publication Critical patent/NO137965B/no
Publication of NO137965C publication Critical patent/NO137965C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D239/08—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms directly attached in position 2
    • C07D239/10—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/215—Radicals derived from nitrogen analogues of carbonic acid

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO3522/72A 1971-10-09 1972-10-03 Analogifremgangsmaate for fremstilling av nye cykliske terapeutisk aktive urinstoffderivater og salter av disse med farmasoeytisk akseptable syrer NO137965C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2150438A DE2150438C3 (de) 1971-10-09 1971-10-09 Cyclische Harnstoffderivate und ihre Salze mit pharmakologisch unbedenklichen Säuren, Verfahren zu ihrer Herstellung und diese enthaltend pharmazeutische Präparate

Publications (2)

Publication Number Publication Date
NO137965B NO137965B (no) 1978-02-20
NO137965C true NO137965C (no) 1978-05-31

Family

ID=5821924

Family Applications (1)

Application Number Title Priority Date Filing Date
NO3522/72A NO137965C (no) 1971-10-09 1972-10-03 Analogifremgangsmaate for fremstilling av nye cykliske terapeutisk aktive urinstoffderivater og salter av disse med farmasoeytisk akseptable syrer

Country Status (31)

Country Link
US (1) US3919233A (ja)
JP (1) JPS5728702B2 (ja)
KR (1) KR780000046B1 (ja)
AR (1) AR204390A1 (ja)
AT (1) AT315834B (ja)
AU (1) AU467578B2 (ja)
BE (1) BE789830A (ja)
CA (1) CA980774A (ja)
CH (1) CH586220A5 (ja)
CS (1) CS200165B2 (ja)
CU (1) CU33794A (ja)
DD (1) DD101159A5 (ja)
DE (1) DE2150438C3 (ja)
EG (1) EG11262A (ja)
ES (1) ES407203A1 (ja)
FI (1) FI57588C (ja)
FR (1) FR2157839B1 (ja)
GB (1) GB1359265A (ja)
HK (1) HK51777A (ja)
HU (1) HU165870B (ja)
IE (1) IE36716B1 (ja)
IL (1) IL40411A (ja)
LU (1) LU66250A1 (ja)
NL (1) NL7213559A (ja)
NO (1) NO137965C (ja)
OA (1) OA04193A (ja)
PL (1) PL89037B1 (ja)
SE (1) SE392896B (ja)
SU (1) SU505355A3 (ja)
YU (2) YU35365B (ja)
ZA (1) ZA726402B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2328346A1 (fr) * 1975-10-17 1977-05-13 Thomson Brandt Dispositif transcodeur de signaux de television en couleurs
DE2837794A1 (de) 1978-08-30 1980-03-13 Asta Werke Ag Chem Fab Basisch substituierte harnstoffe und thioharnstoffe, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
JPS6042795B2 (ja) * 1978-10-23 1985-09-25 日本新薬株式会社 カルバモイルピペラジン誘導体
JPS56127369A (en) * 1980-02-15 1981-10-06 Mitsui Toatsu Chem Inc Nevel piperazine compound, its preparation and utilization
JPS58140078A (ja) * 1982-02-16 1983-08-19 Nippon Tokushu Noyaku Seizo Kk メチル置換テトラヒドロ−２−ピリミジノン誘導体、その製法、その中間体及び該中間体の製法、並びに除草剤
JPS59131202U (ja) * 1983-02-22 1984-09-03 株式会社ケミカルマン 蒸留罐用架台
JPS59176604U (ja) * 1983-05-09 1984-11-26 株式会社　ケミカルマン 溶剤回収用蒸留器
JPS6039301U (ja) * 1983-08-27 1985-03-19 株式会社　ケミカルマン 蒸留器用連接具
JPS60108304U (ja) * 1983-12-23 1985-07-23 株式会社　ケミカルマン 溶剤回収器
JPS60108302U (ja) * 1983-12-23 1985-07-23 株式会社　ケミカルマン 溶剤回収用蒸溜器
JPS60143801A (ja) * 1983-12-29 1985-07-30 Kemikaruman:Kk 溶剤類の回収方法
US5399706A (en) * 1993-03-02 1995-03-21 H. B. Fuller Licensing & Financing, Inc. Imidazolidinone diamine and derivatives thereof
US5496907A (en) * 1993-03-02 1996-03-05 H. B. Fuller Licensing & Financing, Inc. Wet adhesion monomers with ureido functionality and polymers prepared therefrom

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3374237A (en) * 1965-05-21 1968-03-19 American Cyanamid Co 1-phenyl-3-(4-phenyl-1-piperazinoalkyl)-imidazolidinones and imidazolidinethiones
DE1695897C3 (de) * 1966-07-04 1979-02-15 Takeda Chemical Industries Ltd N-Acyl-sydnonimine, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH541568A (de) * 1970-12-07 1973-10-31 Ciba Geigy Ag Verfahren zur Herstellung von neuen Imidazolidinonderivaten

Also Published As

Publication number Publication date
US3919233A (en) 1975-11-11
YU35365B (en) 1980-12-31
FR2157839A1 (ja) 1973-06-08
ES407203A1 (es) 1975-11-01
FI57588B (fi) 1980-05-30
LU66250A1 (ja) 1973-01-23
AU467578B2 (en) 1975-12-04
DE2150438C3 (de) 1979-03-22
OA04193A (fr) 1979-12-31
IE36716B1 (en) 1977-02-02
CU33794A (es) 1974-04-12
AR204390A1 (es) 1976-02-06
GB1359265A (en) 1974-07-10
JPS4844256A (ja) 1973-06-26
DE2150438A1 (de) 1973-04-12
NL7213559A (ja) 1973-04-11
AT315834B (de) 1974-06-10
ZA726402B (en) 1973-06-27
YU248472A (en) 1980-06-30
CS200165B2 (en) 1980-08-29
CA980774A (en) 1975-12-30
AU4700072A (en) 1974-03-28
DD101159A5 (ja) 1973-10-20
SU505355A3 (ru) 1976-02-28
NO137965B (no) 1978-02-20
PL89037B1 (ja) 1976-10-30
FR2157839B1 (ja) 1975-11-28
JPS5728702B2 (ja) 1982-06-18
HK51777A (en) 1977-10-14
FI57588C (fi) 1980-09-10
IL40411A (en) 1976-08-31
KR780000046B1 (en) 1978-03-16
IL40411A0 (en) 1972-11-28
SE392896B (sv) 1977-04-25
HU165870B (ja) 1974-12-28
DE2150438B2 (de) 1978-06-22
BE789830A (fr) 1973-02-01
EG11262A (en) 1977-08-15
YU152779A (en) 1980-10-31
IE36716L (en) 1973-04-09
YU35594B (en) 1981-04-30
CH586220A5 (ja) 1977-03-31

Similar Documents

Publication Publication Date Title
NO137321C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive 3-okso-17alfa-acyloksyandrost-4-en-17beta-karboksylsyreestere
NO140056C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive olefinisk 4-substituerte piperidino-derivater
NO138335C (no) Analogifremgangsmaate for fremstilling av fysiologisk aktive alkanolaminer
NO137965C (no) Analogifremgangsmaate for fremstilling av nye cykliske terapeutisk aktive urinstoffderivater og salter av disse med farmasoeytisk akseptable syrer
NO138374C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-fenoksyfenoksyalkankarboksylsyrederivater
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
NO138566C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,1,3-benzotiadiazol-derivater
NO139685C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolin-derivater
NO136360C (no) Analogifremgangsm}te for fremstilling av nye terapeutisk aktive 2-fenylamino-imidazolin-(2)-er
NO137899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n (1h-tetrazol-5-yl)-kinaldamider
NO141651C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aroyl-substituerte fenyleddiksyrederivater
NO140348C (no) Analogifremgangsmaate til fremstilling av nye terapeutisk aktive 3-(amino-2-hydroksypropoksy)-isoindolin-1-on-forbindelser
NO140012C (no) Analogifremgangsmaate for fremstilling av nye terapeutisk aktive derivater av naftyridin
NO136795C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive indoliner
NO141014C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive 9-alkylamino-erytromyciner og deres salter
NO138063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater
NO139917C (no) Analogifremgangsmaate for fremstilling av 1-aminometyl-2,2-diaryl-cyklopropankarboksamider og salter derav
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO139050C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater
SE410732B (sv) Analogiforfarande for framstellning av anilidderivat med terapeutisk verkan
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
NO137201C (no) Analogifremgangsm}te til fremstilling av nye, substituerte xanton-karboksylsyreforbindelser med profylaktisk og terapeutisk virkning
NO138598C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-(2-delta2-imidazolinyl)-2,2-diarylcyklopropaner og deres syreaddisjonssalter
SE385696B (sv) Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid med terapeutiska egenskaper
NO137998C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tebain- og oripavin-derivater